Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pharmacielo Ltd V.PCLO

Alternate Symbol(s):  PCLOF

Financial Services Healthcare Asset Management
PharmaCielo Ltd. is a Canada-based global company with a focus on ethical and sustainable cultivating, processing and supply of all natural, pharmaceutical-grade medical dried cannabis flower and cannabis products to large channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo... see more

Recent & Breaking News (TSXV:PCLO)

PharmaCielo Announces Intention to Extend Expiry Date of Warrants

Newsfile November 5, 2024

PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024

Newsfile October 7, 2024

PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2024

Newsfile August 16, 2024

Canadian Investment Regulatory Organization Trade Resumption - PCLO

Canada NewsWire July 18, 2024

CORRECTION FROM SOURCE: PharmaCielo Provides Update on Reinstatement for Trading

Newsfile July 17, 2024

PharmaCielo Provides Update on Reinstatement for Trading

Newsfile July 17, 2024

PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2023, and the First Quarter Ended March 31, 2024

Newsfile July 4, 2024

Canadian Investment Regulatory Organization Trading Halt - PCLO

Canada NewsWire May 8, 2024

PharmaCielo Announces Issuance of Failure to File Cease Trade Order

Newsfile May 8, 2024

PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors

Newsfile April 10, 2024

PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil

Newsfile March 26, 2024

Colombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo

Newsfile March 1, 2024

Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products

Newsfile January 4, 2024

PharmaCielo Announces Q3 2023 Financial Results

Newsfile November 29, 2023

PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private Placement

Newsfile October 6, 2023

PharmaCielo Announces Q2 2023 Financial Results

Newsfile August 29, 2023

PharmaCielo Provides Corporate Update

Newsfile August 10, 2023

PharmaCielo Announces Appointment of Marc Lustig as Chairman and CEO

Newsfile July 11, 2023

PharmaCielo Provides Corporate Update

Newsfile June 29, 2023

PharmaCielo Announces Q1 2023 Financial Results

Newsfile May 29, 2023